Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed)
ID: 345396Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) has announced a funding opportunity for innovative pilot mental health services research that does not involve clinical trials, aimed at enhancing mental health service delivery for individuals at risk for mental illness. This initiative seeks to address barriers to access, quality, and outcomes in mental health services, encouraging applications that explore mutable factors affecting service delivery and develop new research methodologies. Eligible applicants include a diverse range of organizations, with a budget limit of $450,000 available over three years, and applications will be evaluated based on their significance, innovation, and alignment with NIH priorities. Interested parties can find more information and submit inquiries via the NIH Grants Information email at grantsinfo@nih.gov, with the application deadline set for May 7, 2025.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Health and Human Services, through the National Institutes of Health (NIH), has issued a Funding Opportunity Announcement (FOA) for innovative pilot mental health services research, focusing on non-clinical trial projects related to mental health service delivery. The goal is to inform high-quality mental health services aimed at individuals with or at risk for mental illness, addressing barriers to access, quality, and outcomes. Applications should explore mutable factors affecting service delivery, develop new research methods, and leverage existing resources for efficient implementation. Key application components include eligibility criteria for diverse organizations, a budget limit of $450,000 over three years, and strict adherence to NIH application guidelines. The FOA emphasizes collaboration with stakeholders to ensure practical relevance and focuses on underserved populations' disparities in mental health access and outcomes. Review criteria will assess the significance, innovation, and approach of proposed research, with applications evaluated for scientific merit and relevance to NIMH priorities. The research aims to enhance the public health impact of mental health services while reducing disparities and improving quality and efficiency within the healthcare system. The submission deadlines begin in early 2023, with awards anticipated by May 2025.
    Similar Opportunities
    Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Mental Health (NIMH), has announced a funding opportunity titled "Innovative Mental Health Services Research Not Involving Clinical Trials (R01 Clinical Trials Not Allowed)." This grant aims to support innovative research that enhances the delivery and quality of mental health services, particularly for underserved populations, by addressing issues such as access, usability, quality, and scalability of these services. Eligible applicants include a wide range of organizations, including educational institutions, non-profits, and governmental bodies, with a focus on projects that incorporate community input and comply with NIH guidelines. Interested parties should note that the application deadline is January 7, 2025, and further details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-23-095.html. For inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R34 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the "Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes" grant, aimed at evaluating therapeutic and service delivery innovations for managing mental health conditions following acute treatment. Applicants are required to conduct pilot trials that assess the feasibility, acceptability, safety, and preliminary effectiveness of interventions designed to improve long-term mental health outcomes, particularly for underserved populations. This initiative underscores the importance of advancing mental health research and fostering effective care transitions beyond acute care settings. Eligible organizations can apply for funding of up to $450,000 over three years, with applications due by January 25, 2025. For further information, interested parties can contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV or visit the funding announcement at http://grants.nih.gov/grants/guide/pa-files/PAR-21-211.html.
    NIMH Exploratory/Developmental Research Grant (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Mental Health (NIMH), is offering the Exploratory/Developmental Research Grant (R21), which aims to support high-risk and innovative research projects that align with the mission of advancing mental health research. This grant is specifically designed for the early stages of research that may lead to significant breakthroughs in clinical and biomedical fields related to mental health, with a funding limit of $275,000 over a two-year period. Eligible applicants include a diverse range of organizations such as higher education institutions, non-profits, and tribal governments, emphasizing the importance of innovative approaches in addressing critical barriers in mental health research. Interested parties should note that applications are due by January 7, 2025, and must adhere to NIH guidelines, with further inquiries directed to grantsinfo@nih.gov.
    Pilot Research Opportunities in Crisis Response Services for Suicide Prevention (R34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Pilot Research Opportunities in Crisis Response Services for Suicide Prevention," aimed at supporting exploratory research into the effectiveness and implementation of crisis response services designed to prevent suicides. This initiative seeks to evaluate the impact of state and local policies on crisis service outcomes, focusing on real-world applications that consider various factors such as clinical presentations, geographic settings, cultural considerations, and health disparities. The total funding available is $2 million across fiscal years 2025-2026, with individual project budgets capped at $225,000 per year for a maximum of three years. Interested applicants can find more information and submission guidelines at the NIH grants website and should direct inquiries to grantsinfo@nih.gov. The application deadline is June 2, 2025.
    Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the R01 grant to support clinical trials aimed at evaluating the effectiveness of treatment, preventive, and service interventions in mental health. The primary objectives of this funding opportunity include conducting rigorous assessments of pharmacologic, psychosocial, and combined interventions, as well as service-level strategies that enhance access and quality of mental health care within community settings. This initiative is crucial for addressing significant public health challenges and advancing evidence-based practices in mental health service delivery. The total funding available is $27 million, with a maximum project period of five years, and applications are due by October 15, 2024. For further information, applicants can contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV or visit the additional information link at http://grants.nih.gov/grants/guide/pa-files/PAR-21-130.html.
    Advancing Learning Health Care Research in Outpatient Mental Health Treatment Settings (R34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Advancing Learning Health Care Research in Outpatient Mental Health Treatment Settings (R34 Clinical Trial Optional)," aimed at enhancing the implementation and sustainability of evidence-based practices in outpatient mental health and substance use treatment settings. This initiative encourages pilot studies that focus on data-driven learning health care, particularly in Certified Community Behavioral Health Clinics (CCBHCs), with objectives including addressing health disparities and improving crisis response services. Eligible applicants include a wide range of organizations, such as higher education institutions and community-based organizations, with funding available up to $450,000 over a three-year project period. The application submission period opens on May 16, 2024, and the final deadline for applications is January 8, 2026; for further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
    Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Mental Health (NIMH), is offering a funding opportunity for the Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required). This initiative aims to support pilot research focused on innovative psychosocial intervention strategies for both adults and children, emphasizing the experimental therapeutic approach to address underlying mechanisms of mental disorders. The funding will facilitate exploratory clinical trials for up to three years, with no specific budget limits, provided they reflect actual project needs, and applications must demonstrate a strong scientific rationale and empirical support. Interested applicants can find more information and application details at the provided NIH link, with a submission deadline of October 15, 2024.
    Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders" (R61/R33 Clinical Trial Required). This initiative aims to support pilot research that develops and tests innovative psychosocial interventions targeting mental disorders in both adults and children, focusing on early-stage exploratory clinical trials to assess how these interventions engage biological, cognitive, or behavioral targets linked to mental health issues. Successful projects will receive funding for up to two years in the R61 phase for preliminary studies, with the potential for an additional three years in the R33 phase contingent upon meeting specified milestones. Interested applicants must adhere to strict guidelines regarding human subject protections and submit their applications through Grants.gov by the deadline of October 15, 2024. For further inquiries, applicants can contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV.
    Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Mental Health (NIMH), is offering a funding opportunity for research projects aimed at evaluating the effectiveness of post-acute interventions and services for mental health conditions affecting youth, adults, and older adults. This initiative encourages clinical trials designed to assess therapeutic strategies that consolidate treatment gains, manage residual symptoms, prevent relapse, and enhance treatment adherence, with a focus on producing statistically powered studies that address chronic or relapsing mental health issues. The program emphasizes the importance of improving long-term mental health outcomes, particularly for underserved populations, and applications are open to a diverse range of eligible entities, including educational institutions and community organizations. Interested applicants should note that the deadline for submissions is January 25, 2025, and can find further details and guidelines at the provided NIH link or contact the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for assistance.
    Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for the Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required). This initiative aims to support innovative clinical trials that investigate novel interventions for mental health conditions, including schizophrenia, depression, and anxiety, with a focus on establishing proof of mechanism and target engagement in the R61 phase and confirming findings on a larger scale in the R33 phase. The total funding commitment for this initiative is $27 million for FY 2022, and eligible applicants include a diverse range of entities such as higher education institutions, nonprofits, and various government organizations, both domestic and foreign. Interested parties should note that the application deadline is October 15, 2024, and can reach out to the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV for further inquiries.